Colleen Tupper - Feb 12, 2024 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Signature
/s/ Colleen Tupper
Stock symbol
COLL
Transactions as of
Feb 12, 2024
Transactions value $
-$887,018
Form type
4
Date filed
2/14/2024, 04:15 PM
Previous filing
Mar 17, 2023
Next filing
May 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Award $0 +40.6K +38.51% $0.00 146K Feb 12, 2024 Direct F1
transaction COLL Common Stock Award $0 +30.9K +21.13% $0.00 177K Feb 12, 2024 Direct F2
transaction COLL Common Stock Tax liability -$568K -16.9K -9.54% $33.70 160K Feb 12, 2024 Direct F3
transaction COLL Common Stock Tax liability -$319K -9.45K -5.91% $33.70 151K Feb 12, 2024 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2025, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
F2 Effective February 12, 2024, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 30,856 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
F3 Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.
F4 Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.